I am trained as a molecular biologist, but have worked at the Department of Infectious Diseases since 2007. I have spent time in Melbourne, Australia and in San Fransisco, US and hence know of the importance of global outlook. I am very interested in the development of novel treatment modalities for both acute and chronic viral infections. I have a position as Professor at the Department of Clinical Medicine.

We have built a world-class clinical translational medicine program where we perform cutting edge testing of novel anti-viral treatment and prevention concepts. We leverage that by complementing our clinical studies with state-of-the-art laboratory methodologies exploring both virology and immunology. Further, I have focused our expertise on novel cell-therapy and gene-therapy technologies with the ambition to be better positioned to translate novel technologies into better treatment options for patients with viral illnesses.   

I teach on a vaccinology course for Medical students and on a course on immune mediated diseases for Molecular Medicine Masters students. Further I supervise multiple bachelor, elective research, medical research year and masters thesis projects focused on laboratory methodologies in viral immunotherapy. I also continous supervise 4-5 phd-students.

I have many national and international academic collaborators. I am part of the founding group on an European HIV Cure network (EU2Cure) with both basic and clinical scientist working together to leverage HIV Cure research in Europe. I also have a good collaborating network locally in Denmark